Renuka SivendranDirector, Analytical Development at Five Prime Therapeutics
Renuka Sivendran is the Director of the Analytical Development Group at Five Prime Therapeutics. Prior to Five Prime, she held different roles at Amgen, including Similarity Leader for the adalimumab and infliximab biosimilar programs and Drug Product Team Leader for the panitumumab and erenumab programs. Prior to Amgen, she worked at Regeneron Pharmaceuticals as a Scientist in the Formulation Development and Protein Chemistry Groups. She obtained her bachelor’s degree in chemistry from the Millersville University of Pennsylvania, her Ph.D. in biophysics from the University of Massachusetts, and she did her postdoctoral fellowship at the National Cancer Institute at the NIH.